ITMCTR2200006837尚未招募未知
Based on multi-omics technology, the objective research and standard formulation of typical poisonous symptoms in traditional Chinese medicine for advanced gastric cancer were carried out
Yangzhou Hospital of Traditional Chinese Medicine, Jiangsu Province0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational study
入排标准
- 年龄范围
- 18 至 75(—)
- 性别
- All
入选标准
- •(1) Age 18-75 years old, gender unlimited;
- •(2) Gastric cancer patients with definite pathological diagnosis.
- •(3) Patients with gastric cancer stage IIIB-IV.
- •(4) Those who meet the diagnostic criteria of TCM Syndromes of spleen deficiency, heat toxin syndrome, blood stasis and toxin accumulation syndrome, and phlegm toxin obstruction.
- •(5) The estimated survival time is more than 3 months.
- •(6) KPS score = 60 points.
- •(7) Compliance is good, and informed consent must be signed before enrollment.
排除标准
- •(1) Major trauma damage such as surgical treatment has occurred in the past month.
- •(2) Those who have serious bleeding or systemic infection, are not controlled, or have purulent and chronic infection, and the wound does not heal.
- •(3) At the same time, patients with hypersplenism, hyperthyroidism, connective tissue disease, tuberculosis and other diseases have not been controlled.
- •(4) Patients with severe cardiovascular system complications, cerebrovascular system complications, active hepatitis, severe liver and kidney dysfunction.
- •(5) Unable to understand, read and fill in the patient self-assessment scale due to knowledge level or intelligence.
- •(6) Any unstable situation or situation that may endanger the safety of patients and their compliance with the study, such as schizophrenia and other serious mental diseases.
- •(7) Other parts of the body are accompanied by or have had malignant tumors (except fully treated cervical carcinoma in situ, basal or squamous cell carcinoma of the skin, or other tumors that have been cured by surgery and have not recurred for at least 5 years).
- •(8) Women of childbearing age with positive urine pregnancy test, lactation or insufficient contraception.
- •(9) The researcher decided that he was not suitable to participate in this study.
研究者
相似试验
进行中(未招募)
1 期
MultipleMS – a study with the aim to accelerate personalised medicine in multiple sclerosis.ewly diagnosed patients with Clinically Isolated Syndrome (CIS) and multiple sclerosis (MS) -both relapsing remitting and primary progressive)EUCTR2017-002634-24-SEKarolinska Institutet150
招募中
不适用
Proteomic and transcriptomic analysis to understand the biology of alcoholic hepatitisCTRI/2023/01/048844ICMR
招募中
不适用
A dynamic, multiple-biomarker approach aiming for individualized treatment of heart failure with preserved ejection fractioHFpEF10019280Heart failureNL-OMON51533niversitair Medisch Centrum200
已完成
3 期
A clinical trial to study the effects of evaluation of efficacy and safety of Fermalac Intravaginal Capsule (Lactobacillus Rhamnosus, Lactobacillus Delbrueckii, Streptococcus Thermophilus) in the treatment of Bacterial Vaginosis among the Indian womeCTRI/2009/091/000919Arun & Co.603 / B Polaris, Off Marol Maroshi Road,Behind Sangeet Plaza, Marol,Andheri (East), Mumbai - 400059India200
招募中
不适用
Aims, contents, and effects of a multidisciplinary inpatient neurological rehabilitation in people with Multiple Sclerosis: a registry studyMultiple sclerosisG35DRKS00033298Reha Zentrum Münster und Karl Landsteiner Institut für interdisziplinäre Rehabilitationsforschung am Reha Zentrum Münster6,000
